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Available online 5 November 2016Background:MicroRNAs (miRNAs or miRs) are post-transcriptional regulators of eukaryotic cells and knowledge
of differences in miR levels may provide new approaches to diagnosis and therapy.
Methods: The present study measured the levels of nine miRs in head and neck squamous cell carcinomas
(HNSCC) and determined whether clinical pathological features are associated with differences in miR levels.
SET (I2PP2A) and PTEN protein levels were also measured, since their levels can be regulated by miR-199b
and miR-21, respectively. Nine miRs (miR-15a, miR-21, miR-29b, miR-34c, miR-100, miR-125b, miR-137, miR-
133b and miR-199b) were measured by real time qRT-PCR in HNSCC samples from 32 patients and eight resec-
tion margins. SET (I2PP2A) and PTEN protein levels were estimated by immunohistochemistry in paired HNSCC
tissues and their matched resection margins.
Results: In HNSCC, the presence of lymph node invasion was associated with low miR-15a, miR-34c and miR-
199b levels, whereas the presence of perineural invasion was associated with low miR-199b levels. In addition,
miR-21 levels were high whereas miR-100 and miR-125b levels were low in HNSCC compared to the resection
margins. When HNSCC line HN12, with or without knockdown of SET, were transfected with miR-34c inhibitor
ormiR-34cmimic, themiR-34c inhibitor increased cell invasion capacitywhilemiR-34cmimic decreased the cell
invasion.
Conclusions:We showed that the levels of speciﬁc miRs in tumor tissue can provide insight into themaintenance
and progression of HNSCC.
General signiﬁcance:MiRNAs are up- or down-regulatedduring cancer development and progression; they canbe
prognosis markers and therapeutic targets in HNSCC.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Since the discovery of small RNAs as regulators of mRNA levels in
C. elegans [1], the miRNAs have emerged as one of the most important
class of post-transcriptional regulators of eukaryotic organisms [2].
The estimated number of coding genes ranges from 2000 [3] to N3000
in humans [4] and themature form of thesemolecules is approximately
22 nucleotides in length. They recognize their targets by base-pairing
interactions between the miRNA 5′-end (the “seed region”) and com-
plementary sequences in the 3′ untranslated regions (3′-UTRs) ofnalyses, Toxicology and Food
Preto, University of São Paulo,
. This is an open access article undermRNA targets [5]. Among other activities, miRs regulate immune cell
differentiation [6], cardiac ageing and function [7], and proliferation/in-
vasion in cancer cells [8].
The analysis of miRNA levels in tumors can provide important infor-
mation about deregulated metabolic pathways in cancer. This method-
ological approach can contribute to the discovery of therapeutic targets,
or even biomarkers [9]. In the present studywe quantiﬁed ninemiRNAs
(miR-15a, miR-21, miR-29b, miR-34c, miR-100, miR-125b, miR-133b,
miR-137 and miR-199b) in 32 samples from HNSCC, and eight of their
resection margins by qRT-PCR, in order to determine whether their
levels are associated with clinical pathological features. These speciﬁc
miRs were chosen because they participate in the regulation of path-
ways considered to be “hallmarks of cancers”, such as cell death, prolif-
eration and migration/invasion [10–14]. We also assessed by
immunohistochemistry in six selected HNSCC samples and theirthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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promotion of cancer cell proliferation [15], and PTEN protein, a classic
tumor suppressor [16]. In HNSCC samples, lower levels of miR-15a,
miR-34c and miR-199b were associated with lymph node invasion,
while lower levels of miR-199b were associated with perineural inva-
sion. By comparing HNSCC samples regarding resection margins, miR-
21 levels were increased while miR-100 and miR-125b levels were de-
creased in tumors. The anti-tumorigenic miR-34c was chosen for func-
tional tests in the HNSCC cell line HN12. MiR-34c inhibitor and miR-
34c mimic were transfected in HN12 cells, promoting either increase
or decrease in HN12 cell invasion capacity, respectively. We concluded
that the levels of miR-15a, miR-34c, miR-199b, miR-21, miR-100 and
miR-125b could provide insights regarding HNSCC behavior, highlight-
ing these molecules as potential new targets in cancer.2. Methods
2.1. Patients and sample information
Thirty-two HNSCC tissue fragments and eight their resection mar-
gins were obtained from the “Sample Bank for Clinical Laboratory Stud-
ies and Molecular Genetics and Bioinformatics Laboratory of the
Genetics Department, Ribeirão Preto Medical School.” The Sample
Bank was created with the approval of the Research Ethics Committee
of the Ribeirão Preto Medical School Hospital (HCRP) (Case No. 4911/
2008 HCRP). Some clinical pathological features of patients and tumors
are listed in Table 1.Table 1
Epidemiologic and pathological features of 32 patients with head and neck squamous car-
cinoma cell included in the present study.
Feature N (%)
Sex Female 1 (3.1)
Male 31 (96.9)
Tumor site Larynx 9 (28.1)
Larynx (glottic and supraglottic) 1 (3.1)
Larynx (glottic) 10 (31.2)
Larynx (glottic and subglottic) 1 (3.1)
Larynx (supraglottic) 7 (21.9)
Oropharynx 2 (6.2)
Epiglottis 1 (3.1)
Oral cavity 1 (3.1)
Age (years) Average (SD) 61.1 (10.7)
Median (min–max) 58.5 (40–83)
Smokea No –
Yes 27 (100)
Alcoholb No –
Yes 26 (100)
Tumor sizec T1 6 (18.8)
T2 7 (21.8)
T3 5 (15.6)
T4 13 (40.6)
Lynph node invasionc N0 23 (71.9)
N1 1 (3.1)
N2 1 (3.1)
N2a 1 (3.1)
N2b 3 (9.4)
N2c 2 (6.3)
Inﬂammatory inﬁltrate Peritumoral 32 (100)
Intratumoral 2 (6.3)
Perineural invasion No 27 (84.4)
Yes 5 (15.6)
Differentiation grade I 4 (12.5)
II 14 (43.75)
III 14 (43.75)
a Four cases without information.
b Five cases without information.
c One case without information.2.2. Real-time quantitative reverse transcription PCR (real time qRT-PCR)
Total RNA was extracted from 32 tumors and 8 margins with
TRIzol® reagent (15596-26, Life technologies, USA). RNA concentration
was determined using absorbance (A) at 230 nm; values ranging from
2.0 to 2.2 for A260/A280 and A260/A230 ratios were considered for
RNA quality. Two measurements were carried out and differences of
b5% were observed. Samples were stored at−80 °C.
The TaqMan® MicroRNA reverse transcription kit (4366596,
Applied Biosystems, USA) was used to convert 5.0 ng of total RNA to
complementary DNA (cDNA) for each mature miRNA studied. The
TaqMan® Small RNA Assays kit (4364031E, Applied Biosystems) was
used to identify and measure by qRT-PCR miR-15a (assay: 000389, Ap-
plied Biosystems), miR-21 (assay: 000397), miR-29b (assay: 000413),
miR-34c (assay: 000428), miR-100 (assay: 000437), miR-125b (assay:
000449), miR-133b (assay: 591), miR-137 (assay: 000593) and miR-
199b (assay: 000500) in tumor and resection margin tissues. The rela-
tive level of each miRNA was normalized to the small nucleolar RNA
RNU6b (assay: 4427975, Applied Biosystems), used as endogenous con-
trol to normalize real time qRT-PCR data and to compare the 2−ΔCt
values of tumor and resection margin samples, using the equation
2−ΔCt, where ΔCt = (Ct miRNA − Ct RNU6b). The assays were per-
formed using an Eppendorf Mastercycler Realplex 4S apparatus
(Eppendorf, Germany). Data are reported as median (min–max) 2−ΔCt
of two independent experiments, each one carried out in triplicate.
2.3. Immunohistochemistry for SET and PTEN in HNSCC samples and their
respective resection margins
Formalin-ﬁxed and parafﬁn-embedded (FFPE) sections (10 μm) ob-
tained by microdissection of 6 tumors and their respective resection
margins were subjected to immunostaining, as previously described
[17]. The antibody against SET protein (sc-5655; Santa Cruz Biotechnol-
ogy, USA) was used at 1:200 dilution, and the antibody against PTEN
(9559 - Cell Signaling, USA) at 1:100 dilution. The Dako LSAB+
System-HRP (K0690, DakoNorth America, USA) kit was used as second-
ary antibody. Immunoreactive cells were visualized after incubation
with the chromogenic substrate diaminobenzidine (DAB) (K3468,
Dako) for 10 min at room temperature. Photomicrographs of the sec-
tions at 20× magniﬁcations were obtained using a digital camera
(AxioCam MRC, Carl Zeiss, Germany) coupled to an Axiovert 40 bright
ﬁeld lightmicroscope (Carl Zeiss). Five ﬁeldswere scored. The immuno-
staining intensity was scored as follows: 0 = negative, 1 = weak and
2 = moderate or strong. The score was multiplied by 1.0 or 2.0 to cor-
rect for the percentage of cells stained: 1 corresponds to b50% cells
stained and 2 correspond to ≥50% cells stained [18]. Data are reported
as median and min–max score.
2.4. Cell culture
The tumorigenic and metastatic HNSCC cell line HN12 was cultured
in Dulbecco's Modiﬁed Eagle Medium (D5648 DMEM Sigma-Aldrich,
USA) supplemented with 10% fetal bovine serum (FBS - GIBCO), 1%
antimycotic and antibacterial agents (10,000 U/mL penicillin stock solu-
tion, 10 mg/mL streptomycin, and 25 mg/mL amphotericin B - Sigma
A5955) at 37 °C, in the presence of 5% CO2, in a CO2 incubator.
2.5. MiRNA transfection in HNSCC cells
HN12shCTRL and HN12shSET cells, established by Sobral et al.
[15], were transfected with 50 nM HSA-miRNA-34c miRNA inhibitor
(4464084 Ambion, USA) or 50 nM HSA-miR-34c miRNA-mimic
(4464066 Ambion) for functional studies. MiR-34c inhibitor and
miR-34c mimic were transfected by using the HiPerFect® reagent
(Qiagen - 301705), according to manufacturer's instructions.
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For the invasion assay, Matrigel (BD Biosciences, catalogue number:
354230) was diluted 1:1with serum-free medium, and used to coat the
ﬁlter membranes. HN12shControl and HN12shSET cells (1 × 105)
transfected or not with the miR-34c inhibitor and miR-34c mimic
were suspended in 250 μL serum-free DMEM, and seeded into the
upper compartment of the transwell chamber (8.0 μm transparent PET
membrane, Falcon, catalogue number: 353097); DMEM containing
10% FBSwas used in the lower chamber for stimulation. After 72 h incu-
bation, the medium in the upper chamber was removed, and ﬁlters
were ﬁxed in 10% formalin for 15 min. The cells on the lower surface
were stained with 4′,6-diamidino-2-phenylindole (DAPI; Sigma). Five
ﬁelds were photographed at ×200 original magniﬁcation using a Zeiss
Axiovert 40 inverted microscope, and processed using the AxioVision
Rel. 4.8.2 software. Cells were counted using the ImageJ software. The
invasion datawere reported asmean (±SD) number of cells per micro-
scopic ﬁeld; ﬁve ﬁelds were analyzed.
2.7. Statistical analysis
The SPSS Statistics© version 19.0 and GraphPad Prism 5.03 soft-
wares were used for statistical analysis. The level of signiﬁcance was
set at p b 0.05.
3. Results
3.1. Low miR-15a, miR-34c and miR-199b levels were observed in HNSCC
samples from patients with lymph node invasion, and low miR-199b levels
in HNSCC samples from patients with perineural invasion
Signiﬁcant clinical pathological associations were found in the pres-
ent study concerning miR-15a, miR-34c and miR-199b levels (Table 2).
Their levels were signiﬁcantly lower in tumors from patients with
lymph node invasion (LNI+) compared to patients without LNI
(LNI−). The median 2−ΔCt miR-15a value was 3.63 (0.40–13.18) for
LNI− patients and 2.28 (0.87–6.32) for LNI+ patients (p = 0.032).
The median 2−ΔCt miR-34c value was 0.57 (0.01–4.26) for LNI− pa-
tients and 0.37 (0.04–1.21) for LNI+ patients (p= 0.022). The median
2−ΔCt miR-199b value was 0.24 (0.02–1.39) for LNI− patients and 0.15Table 2
MiRNA content of HNSCC tissue with or without lymph node invasion (LNI+ or LNI−) or perin
(min–max). The Mann-Whitney test was used to compare data for tissue with or without inva
icance was set at p b 0.05 (*). Statistically different values for each miR are given in bold type.
Lymph node invasion
−(N = 23) +(N = 8)
2−ΔCt median (min–max)
miR-15a 3.63 (0.40–13.18) 2.28 (0.87–6.32)
p = 0.032 (*)
miR-21 382.68 (43.11–1820.35) 242.19 (71.01–1038.
p = 0.327
miR-29b 2.53 (0.50–13.18) 0.74 (0.33–5.46)
p = 0.070
miR-34c 0.57 (0.01–4.26) 0.37 (0.04–1.21)
p = 0.022 (*)
miR-100 32.90 (3.05–122.79) 14.83 (5.06–91.77)
p = 0.319
miR-125b 43.11 (10.13–198.09) 30.91 (9.58–172.45)
p = 0.463
miR-133b 0.624 (0.136–1370.04) 0.790 (0.067–269.57
p = 0.557
miR-137 0.103 (0.021–2.321) 0.072 (0.007–0.362)
p = 0.528
miR-199b 0.24 (0.02–1.39) 0.15 (0.01–0.58)
p = 0.011 (*)(0.01–0.58) for LNI+ patients (p= 0.011). Speciﬁcally regarding miR-
199b, the levelswere higher in tumors frompatientswithout perineural
invasion (2−ΔCt median = 0.24 (0.02–1.39) compared to tumors from
patients with perineural invasion (2−ΔCt median = 0.11 (0.01–0.37)
(p= 0.040).
3.2. MiR-21 levels were higher whereasmiR-100 andmiR-125b levels were
lower in HNSCC tissue samples compared to resection margins
The comparison of miRNAs levels between HNSCC samples and
resection margins revealed the following: in tumors, miR-21 levels
were signiﬁcantly higher, whereas miR-100 and miR-125b levels
were signiﬁcantly lower compared to resection margins (Table 3).
Median (min–max) miR-21 2−ΔCt was 371.0 (43.1–1820.3) in tu-
mors and 136.7 (16.1–744.4) in margins (p = 0.036). The miR-100
value was 24.7 (3.0–122.8) and 93.0 (27.3–171.2) in tumors and
margins (p = 0.017), respectively. Another miRNA, miR-125b,
showed a median 2−ΔCt of 37.5 (9.6–198.1) and 92.8 (26.0–352.1)
in tumors and margins (p = 0.018), respectively.
3.3. PTEN protein score was lower andmiR-21 levels were higher in HNSCC
samples compared to their respective resection margins
Meng et al. [19] reported increased miR-21 levels in human hepato-
cellular carcinoma compared to margin cells. These higher levels were
capable of inducing growth and spread of cancer cells through the re-
duction of mRNA coding for Tumor Supressor Protein “PTEN”, an
establishedmiR-21 target. The PTEN scorewas signiﬁcantly lower in tu-
mors compared to resectionmargins. Themedian PTEN score value was
1 (0–2) in tumors and 2 [1–4] inmargins (p=0.027) (Fig. 1-A and Sup-
plementary Fig. 1-A). Conversely, the values for miR-21 were 574.4
(196.7–1820.3) and 193.0 (16.1–744.4) in tumors and margins (p =
0.031), respectively (Fig. 1-B).
3.4. HNSCC samples showed a higher SET protein level and lowermiR-199b
levels compared to their respective resection margins
Chao et al. [20] reported thatmRNA coding for SET protein is a target
of miR-199b, which is present at lower levels in choreocarcinoma than
in normal cells. In order to determine whether HNSCC tumors alsoeural invasion (PNI+ or PNI−), obtained by qRT-PCR. Data are reported as 2−ΔCt median
sion (two categories) using the SPSS Statistics© version 19.0 software. The level of signif-
Perineural invasion
−(N = 27) +(N = 5)
2−ΔCt median (min–max)
2.99 (0.4–13.18) 1.43 (0.95–12.47)
p = 0.944
29) 382.68 (43.11–1820.35) 196.72 (71.01–625.99)
p = 0.170
1.88 (0.33–13.18) 1.12 (0.33–8.57)
p = 0.754
0.51 (0.01–4.26) 0.17 (0.04–0.83)
p = 0.139
26.72 (3.05–122.79) 21.71 (5.06–73.52)
p = 0.631
43.11 (10.13–198.09) 13.74 (9.58–163.14)
p = 0.082
) 0.624 (0.136–1370.04) 1.11 (0.067–259.57)
p = 0.815
0.088 (0.007–2.321) 0.135 (0.009–0.242)
p = 0.603
0.24 (0.02–1.39) 0.11 (0.01–0.37)
p = 0.040 (*)
Table 3
Comparison of miRNA content of tumors (N = 32) and non-tumor resection margins
(N = 8). Data were obtained by qRT-PCR and are reported as 2−ΔCt median (min–max).
The Wilcoxon test was used to compare the data for each miR using the SPSS Statistics©
version 19.0 software. The level of signiﬁcancewas set at p b 0.05 (*). Statistically different
values for each miR are given in bold type.
Tumor (N = 32) Margin (N = 8) p value
2−ΔCt median (min–max) 2−ΔCt median (min–max)
miR-15a 2.86 (0.40–13.18) 2.73 (1.45–5.28) 0.123
miR-21 371.04 (43.11–1820.35) 136.72 (16.11–744.43) 0.036 (*)
miR-29b 1.38 (0.33–13.18) 2.40 (1.27–5.17) 0.208
miR-34c 0.46 (0.012–4.26) 0.17 (0.066–15.89) 0.866
miR-100 24.75 (3.05–122.79) 93.05 (27.28–171.25) 0.017 (*)
miR-125b 37.53 (9.58–198.09) 92.85 (25.99–352.14) 0.018 (*)
miR-133b 0.64 (0.067–1370.04) 2.44 (0.39–23.59) 0.161
miR-137 0.10 (0.007–2.32) 0.071 (0.028–0.166) 0.285
miR-199b 0.23 (0.013–1.39) 0.35 (0.093–1.92) 0.069
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tive resectionmargins, chosen based onmiR-199b levels, were assessed
As shown in Fig. 1-C and illustrated in Supplementary Fig. 1-B,while the
median SET score was 2 (0–4) in tumors and 1 (0–1) in margins (p=
0.045), the median miR-199b 2−ΔCt value was 0.18 (0.01–0.92) in tu-
mors and 0.45 (0.25–1.92) in margins (p= 0.026) (Fig. 1-D).Fig. 1. (A) Comparison ofmedian PTEN score values obtained by immunohistochemistry (IHC) a
non-tumor resection margins from the same patients (N = 6). Values above the box plots ar
(C) Comparison of median (min–max) SET score obtained by immunohistochemistry and o
non-tumor resection margins from the same patients (N = 6). Values above the box plots are
The signiﬁcance of the differences between tumors and their respective resection margins was3.5. MiR-34c controls cell invasion in HNSCC
We have reported that SET knockdown in the HNSCC cell line HN12
increased its invasion capability [15]. Here, we have used HN12 cell line
either with (HN12shSET) or without (HN12shControl) SET knockdown
in order to determine the miR-34c impact in their invasiveness. The
transfection of miR-34c inhibitor caused an increase from 13.5 (±9.7)
to 289.3 (±80.7) in HN12shControl cell invasion, against an increase
from 238.0 (±86.3) to 408 (±130.0) in HN12shSET cell invasion
(Fig. 2). On the other hand, while the transfection of miR-34c mimic
did not signiﬁcantly alter HN12shControl cell invasion capacity
(13.5 ± 9.7 to 25.3 ± 42.2 values), it strongly reduced the HN12shSET
cell invasion capacity (238.0 ± 86.3 to 34.3 ± 30.2 values) (Fig. 2).4. Discussion
Lymph node invasion (LNI) is one of the most important indicators
of distant metastasis and survival in the majority of cancer types [21].
LNI means that tumor cells have acquired the ability to penetrate
blood vessels and possibly survive in the vascular environment, to circu-
late through the body, and to initiate new tumors at secondary sites
[22].nd of (B)medianmiR-21 levels by real time qRT-PCR inHNSCC tumors and their respective
e (A) median (min–max) PTEN scores and (B) median (min–max) miR-21 2−ΔCt values.
f (D) median (min–max) miR-199b 2−ΔCt values in HNSCC tumors and their respective
(C) median (min–max) SET scores and (D) median (min–max) miR-199b 2−ΔCt values.
determined by the Mann-Whitney test using the GraphPad Prism 5.03 software.
Fig. 2.MiRNA-34c inhibits invasion in HNSCC cells. HN12shControl and HN12shSET cells
were transfected with miR-34c inhibitor or miR-34c mimic, submitted to transwell®
chamber (8.0 μm pore size membrane) with Matrigel™, and their invasion capacity was
determined. Values are reported as mean and standard deviation. Statistical signiﬁcance
was assessed by Student's t-test in GraphPad Prism 5.01. *Means p b 0.05.
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15a, miR-34c and miR-199b levels and lymph node metastasis in
HNSCC. In tumors from patients with lymph node metastasis (N+),
the levels of these three miRNAs were lower when compared to those
of patients without LNI (N0). MiR-15a is a tumor suppressor miR that
targets the 3′-UTR of anti-apoptotic protein Bcl2, which is decreased
in chronic lymphocytic leukemia (CLL) [23]. Li et al. [14] reported that
overexpression of miR-34c in nasopharyngeal carcinoma suppressed
tumor growth and metastasis by targeting the proto-oncogene MET.
Chao et al. [20] reported that, when the level of miR-199b is reduced,
the SET level is higher and cells havemore proliferative capacity. There-
fore, the decreased levels of these miRs may confer an advantage
concerning migration/invasion and proliferation of tumor cells.
Perineural invasion (PNI) is the process of neoplastic invasion of
nerves, reported ﬁrst in head and neck cancers, that exhibit a predilec-
tion for growth along nerves (reviewed by [27]). PNI can be a source
of distant tumor spread and can be associated with a poor prognosis
in distinct cancer types such as pancreatic [24], gastric [25], rectal [26]
and prostate [27] cancers.
Reduced levels of miR-199b in HNSCC are reported here for the ﬁrst
time. Chao et al. [20] reported that SET protein is amiR-199b target. The
authors described decreased miR-199b levels in human choriocarcino-
ma, while SET protein levels and cell proliferation capacity were in-
creased compared to normal cells. This evidence suggests proliferative
advantages for HNSCC with PNI, since the reduced miR-199b levels in-
duce increased SET protein levels and consequently lead tomore prolif-
eration [20].
The present study showed higher miR-21 levels in HNSCC samples
compared to the resectionmargins. MiR-21 has been reported to simul-
taneously regulatemultiple cellular programs that enhance cell prolifer-
ation, apoptosis and tumor invasiveness by targeting PTEN, RECK and
Bcl-2 in lung squamous carcinoma [13].
We also observed lower miR-100 and miR-125b levels in HNSCC
samples compared to resection margins (Table 3), in agreement with
data reported by Henson et al. [28] regarding reduced miR-100 and
miR-125b levels in oral squamous cell cancer (OSCC) lines. After trans-
fection of these twomiRs in OSCC lines, Henson et al. [28] reported that
they reduced cell proliferation by reducing the levels of many mRNAs,
including those that code for MMP13, EGFR3 (miR-100) and KLF13
(miR-125b) proteins. On the basis of these reports, our results suggest
that reducedmiR-100 andmiR-125b levels are important for cell prolif-
eration capacity.
In the present study, we demonstrated that miR-21 is up-regulated
in HNSCC tissues when compared to non-tumor resection margin.
In Fig. 1, the tumor and resection margin tissues were obtained from
the same patients and tumor tissues with highermiR-21 levels present-
ed low PTEN score, while margin tissues with lower miR-21 levelspresented high PTEN score. This is a new evidence that miR-21 is an im-
portant miR in HNSCC, and miR-21 increase is associated with low
PTEN. MiR-21 was also higher in laryngeal and hypopharyngeal cancer,
and its levels were reversely correlated with tumor suppressor “PTEN”
protein levels [29].
Another protein assessed in the present study by immunohisto-
chemistry was SET (I2PP2A). Leopoldino et al. [30] reported that SET
is accumulated in HNSCC and contributes to cell survival and antioxi-
dant defense. Almeida et al. [31] reported that SET interacts with ribo-
nucleoprotein hnRNPK and enhances cell proliferation in OSCC lines.
We demonstrated higher SET scores and lower miR-199b in matched
HNSCC samples compared to their resection margins. These results are
consistent with a role of miR-199b in the control of SET levels and sug-
gest the participation of miR-199b in the control of cell proliferation by
down-regulation of SET protein in HNSCC.
A strategy to conﬁrm the biological relevance of a speciﬁc miRNA is
the ectopic expression or inhibition [14]. In order to validatemiR-34c as
ametastasis suppressor in HNSCC,we transfected themiR-34c inhibitor
and miR-34c mimic in both HN12shControl and HN12shSET cells. The
transfection of miR-34c inhibitor signiﬁcantly raised the number of
invasive HN12shControl cells, whereas the transfection of miR-34c
mimic signiﬁcantly reduced the number of invasive HN12shSET cells.
Since miR-34c was reduced in patients with lymph node invasion, this
result stresses the participation of thismiRNA in the regulation of cancer
cell invasion and metastasis. Moreover, our ﬁndings suggest that SET
protein is regulating invasion by target regulated by miR-34c.
5. Study limitations
Limitations of the current study: small sample size and cancer-
speciﬁc survival data.
6. Conclusions
The results of the present study demonstrate thatmiRs participate in
the malignant transformation in HNSCC. The association of clinical-
pathological parameters observed for miR-15a, miR-34C and miR-
199b opens a window regarding molecules to be investigated in depth
as circulating molecules, as therapeutic targets and/or biomarkers for
early HNSCC diagnosis. The increased miR-21 levels, the reduced miR-
100 and miR-125b levels, and the higher SET protein levels confer a
higher proliferative capacity and lower cell death levels to HNSCC. The
increase ofmiR-21 and the reduction of PTEN levels contribute to cancer
growth and spread. The reduced miR-199b levels observed in HNSCC
tumors, in association with increased SET levels, have been reported
to provide proliferation advantages for choriocarcinoma cells [12,21].
Brieﬂy, the present study shows that deregulation of miRNAs, with
consequent impact on the levels of proteins controlling cancer hall-
marks such as cell proliferation, apoptosis or migration/invasion,
forms a panel that establishes favorable conditions for generation and
maintenance of HNSCC. Therefore, these miRs and proteins are strong
candidates as potential targets for cancer diagnosis and/or treatment.
Supplementary data to this article can be found online at doi:10.
1016/j.bbacli.2016.11.001.
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